[{"quiz_id": "20251225T200227925Z_deepseek-v3.2_seed134", "question_id": "20251225T200227925Z_deepseek-v3.2_seed134-001", "question": "A 28-year-old male presents to the ED with 2 hours of severe, tearing interscapular back pain radiating to the left flank. He has a history of Marfan syndrome. Vital signs: BP 180/110 mmHg in right arm, 100/60 mmHg in left arm, HR 120 bpm, SpO2 98% on room air. ECG shows sinus tachycardia. Portable CXR shows a widened mediastinum. Bedside transthoracic echocardiogram shows normal left ventricular function, no pericardial effusion, and a normal aortic root at the level of the sinuses of Valsalva. What is the most appropriate immediate management step?", "options": ["A. Administer IV labetalol to target systolic BP <120 mmHg", "B. Obtain an emergent CT angiogram of the chest/abdomen/pelvis", "C. Start an IV esmolol infusion to target heart rate <60 bpm and systolic BP <120 mmHg", "D. Administer IV morphine for pain control and arrange transfer to the operating room", "E. Perform transesophageal echocardiography in the ED to better visualize the aortic arch"], "answer": "C", "answer_index": 2, "explanation": "In acute aortic dissection (strongly suggested by pain, pulse deficit, and mediastinal widening), the priority is to reduce shear stress via heart rate and blood pressure control before definitive imaging. Esmolol is the preferred agent as it is a short-acting beta-blocker; pure vasodilators like nitroprusside can increase shear stress if used without beta-blockade. While CT angiography (B) is the definitive diagnostic test, controlling hemodynamics first minimizes the risk of extension or rupture during the scan. Labetalol (A) is appropriate but the specified target is too aggressive initially; a systolic BP of 100-120 mmHg is the goal. Direct transfer (D) or TEE (E) without hemodynamic control is dangerous.", "generator_model": "deepseek-v3.2", "seed": 134, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Emergency Medicine", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: Young man with Marfan syndrome, abrupt severe tearing interscapular pain, marked inter-arm BP difference, tachycardia, widened mediastinum on CXR: classic for acute aortic dissection. Bedside TTE shows normal root but does not exclude dissection, especially arch/descending. In acute suspected dissection, immediate priority is reducing aortic shear stress with IV beta‑blockade to HR <60 and SBP ~100–120 before or concurrent with definitive imaging.\\nOption C (IV esmolol to target HR<60 and SBP<120) correctly captures short‑acting beta‑blocker use with appropriate dual targets and is the best immediate step. Option A (IV labetalol) is reasonable agent choice but framed only as BP targeting; the critique that the target is “too aggressive” is debatable, but C is clearly superior because it explicitly emphasizes HR and BP control and uses the preferred titratable drug. B (CTA) is needed next but not before stabilizing hemodynamics. D and E focus on surgery/TEE without prior hemodynamic control, increasing risk.\\nMain medical accuracy issues: Minor—wording about BP target aggressiveness. Minimal fix: Rephrase A to include HR target or specify a more realistic initial SBP range so it is clearly inferior to C’s esmolol regimen.\\n\",\"medical_accuracy_score\":\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: Young man with Marfan syndrome, abrupt severe tearing interscapular pain, marked inter-arm BP difference, tachycardia, widened mediastinum on CXR: classic for acute aortic dissection. Bedside TTE shows normal root but does not exclude dissection, especially arch/descending. In acute suspected dissection, immediate priority is reducing aortic shear stress with IV beta‑blockade to HR <60 and SBP ~100–120 before or concurrent with definitive imaging.\nOption C (IV esmolol to target HR<60 and SBP<120) correctly captures short‑acting beta‑blocker use with appropriate dual targets and is the best immediate step. Option A (IV labetalol) is reasonable agent choice but framed only as BP targeting; the critique that the target is “too aggressive” is debatable, but C is clearly superior because it explicitly emphasizes HR and BP control and uses the preferred titratable drug. B (CTA) is needed next but not before stabilizing hemodynamics. D and E focus on surgery/TEE without prior hemodynamic control, increasing risk.\nMain medical accuracy issues: Minor—wording about BP target aggressiveness. Minimal fix: Rephrase A to include HR target or specify a more realistic initial SBP range so it is clearly inferior to C’s esmolol regimen.\n", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251225T200227925Z_deepseek-v3.2_seed134", "question_id": "20251225T200227925Z_deepseek-v3.2_seed134-002", "question": "A 42-year-old woman with a 15-year history of treatment-resistant schizophrenia, managed on clozapine 450 mg daily, is admitted for evaluation of progressive confusion, ataxia, and urinary incontinence over 4 weeks. MRI brain shows symmetrical, confluent T2/FLAIR hyperintensity in the periventricular white matter and corpus callosum, with no contrast enhancement. Lumbar puncture reveals 5 WBCs (all lymphocytes), protein 80 mg/dL, glucose 60 mg/dL (serum glucose 95 mg/dL), and negative oligoclonal bands. What is the most likely diagnosis?", "options": ["A. Progressive multifocal leukoencephalopathy (PML)", "B. Clozapine-induced neuroleptic malignant syndrome", "C. HIV-associated neurocognitive disorder", "D. Marchiafava-Bignami disease", "E. Acute disseminated encephalomyelitis (ADEM)"], "answer": "D", "answer_index": 3, "explanation": "Marchiafava-Bignami disease is a rare disorder of corpus callosum demyelination and necrosis classically associated with chronic alcoholism, but it is also reported with severe nutritional deficiencies, which can occur in chronic schizophrenia due to self-neglect or poor intake. The clinical triad (confusion, ataxia, incontinence) and MRI findings of corpus callosum involvement are characteristic. PML (A) typically shows asymmetric, multifocal white matter lesions, often in immunocompromised hosts. Neuroleptic malignant syndrome (B) presents acutely with fever, rigidity, and autonomic instability. ADEM (E) is typically monophasic and often follows infection/vaccination, with more acute presentation and possible enhancement.", "generator_model": "deepseek-v3.2", "seed": 134, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\n\\nKey stem clues: Middle-aged woman; subacute (4-week) progression of confusion, ataxia, and urinary incontinence; MRI with symmetrical, confluent T2/FLAIR hyperintensity in periventricular white matter and corpus callosum without enhancement; mild lymphocytic CSF pleocytosis, elevated protein, normal glucose; long-standing schizophrenia on clozapine, implying possible severe self-neglect and malnutrition.\\n\\nThese features strongly suggest Marchiafava-Bignami disease (corpus callosum demyelination/necrosis, often nutritional), making D the best answer. PML usually produces asymmetric, multifocal lesions and is classically in overtly immunocompromised patients; the vignette lacks such risk factors and stresses symmetry. HIV-associated neurocognitive disorder would require HIV risk or serostatus and is not characteristically limited to corpus callosum involvement. Neuroleptic malignant syndrome is acute with fever, rigidity, marked CK elevation and not defined white-matter lesions. ADEM is more acute, post-infectious/vaccine, often with enhancement and more inflammatory CSF.\\n\\nMain issues: The vignette does not explicitly document alcoholism or nutritional deficiency, so some inference is required, but the imaging pattern and triad make D uniquely best. No major medical inaccuracies.\\n\\nMinimal fix: Explicitly state evidence of malnutrition or chronic alcoholism to strengthen linkage to Marchiafava-Bignami disease and remove residual ambiguity with other leukoencephalopathies.\",\"medical_accuracy_score\":\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\n\nKey stem clues: Middle-aged woman; subacute (4-week) progression of confusion, ataxia, and urinary incontinence; MRI with symmetrical, confluent T2/FLAIR hyperintensity in periventricular white matter and corpus callosum without enhancement; mild lymphocytic CSF pleocytosis, elevated protein, normal glucose; long-standing schizophrenia on clozapine, implying possible severe self-neglect and malnutrition.\n\nThese features strongly suggest Marchiafava-Bignami disease (corpus callosum demyelination/necrosis, often nutritional), making D the best answer. PML usually produces asymmetric, multifocal lesions and is classically in overtly immunocompromised patients; the vignette lacks such risk factors and stresses symmetry. HIV-associated neurocognitive disorder would require HIV risk or serostatus and is not characteristically limited to corpus callosum involvement. Neuroleptic malignant syndrome is acute with fever, rigidity, marked CK elevation and not defined white-matter lesions. ADEM is more acute, post-infectious/vaccine, often with enhancement and more inflammatory CSF.\n\nMain issues: The vignette does not explicitly document alcoholism or nutritional deficiency, so some inference is required, but the imaging pattern and triad make D uniquely best. No major medical inaccuracies.\n\nMinimal fix: Explicitly state evidence of malnutrition or chronic alcoholism to strengthen linkage to Marchiafava-Bignami disease and remove residual ambiguity with other leukoencephalopathies.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251225T200227925Z_deepseek-v3.2_seed134", "question_id": "20251225T200227925Z_deepseek-v3.2_seed134-003", "question": "A 55-year-old man with a history of alcohol use disorder is brought in by his family for increasing paranoia, visual hallucinations of insects crawling on walls, and agitation over 3 days. He last drank 4 days ago. He is started on a lorazepam taper for suspected alcohol withdrawal. On hospital day 2, he becomes febrile (38.8°C), rigid, and obtunded. Creatine kinase is 12,000 U/L. Urinalysis shows dark brown urine with 3+ blood but no RBCs on microscopy. Which of the following is the most likely precipitant of this acute deterioration?", "options": ["A. Undiagnosed neuroleptic malignant syndrome from a newly prescribed antipsychotic", "B. Serotonin syndrome from a selective serotonin reuptake inhibitor started for depression", "C. Acute bacterial meningitis complicating alcohol withdrawal", "D. Delirium tremens with severe autonomic hyperactivity", "E. Rhabdomyolysis from a prolonged period of immobility and agitation"], "answer": "A", "answer_index": 0, "explanation": "This describes neuroleptic malignant syndrome (NMS) precipitated by an antipsychotic likely given for agitation/hallucinations in the setting of alcohol withdrawal. The key is recognizing that patients with alcohol withdrawal psychosis are often treated with antipsychotics (e.g., haloperidol), which can trigger NMS. The fever, rigidity, and markedly elevated CK with myoglobinuria are classic. While delirium tremens (D) can cause fever and agitation, it does not typically cause severe rigidity. Serotonin syndrome (B) presents with hyperreflexia, clonus, and hyperkinesis, not rigidity. Rhabdomyolysis (E) may occur from agitation but does not explain the fever and rigidity combination.", "generator_model": "deepseek-v3.2", "seed": 134, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\n\\nKey stem clues: initial alcohol withdrawal with lorazepam taper; then on hospital day 2, new fever (38.8 °C), marked rigidity, obtundation, CK 12,000 U/L, and dark urine with 3+ blood but no RBCs (myoglobinuria). This triad of hyperthermia, “lead-pipe” rigidity, encephalopathy, and severe rhabdomyolysis with myoglobinuria is classic for neuroleptic malignant syndrome (NMS), typically precipitated by dopamine antagonist use (e.g., haloperidol) frequently given for agitation in alcohol-withdrawal psychosis.\\n\\nChoice A is therefore the best answer: undiagnosed NMS from a newly prescribed antipsychotic. B (serotonin syndrome) is less consistent because that syndrome features hyperreflexia, clonus, and hyperkinesis rather than rigidity. C (meningitis) does not explain the extreme CK elevation and myoglobinuria. D (delirium tremens) causes autonomic hyperactivity and agitation but not severe rigidity and massive rhabdomyolysis. E (immobility/agitation rhabdomyolysis) lacks an explanation for new fever and rigidity.\\n\\nMain medical accuracy issues: None significant; the associations and differentials are accurate. Minimal fix: explicitly state that an antipsychotic (e.g., haloperidol) was started for agitation to more transparently link the precipitant to NMS, though the item is already solvable.\\n\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\n\nKey stem clues: initial alcohol withdrawal with lorazepam taper; then on hospital day 2, new fever (38.8 °C), marked rigidity, obtundation, CK 12,000 U/L, and dark urine with 3+ blood but no RBCs (myoglobinuria). This triad of hyperthermia, “lead-pipe” rigidity, encephalopathy, and severe rhabdomyolysis with myoglobinuria is classic for neuroleptic malignant syndrome (NMS), typically precipitated by dopamine antagonist use (e.g., haloperidol) frequently given for agitation in alcohol-withdrawal psychosis.\n\nChoice A is therefore the best answer: undiagnosed NMS from a newly prescribed antipsychotic. B (serotonin syndrome) is less consistent because that syndrome features hyperreflexia, clonus, and hyperkinesis rather than rigidity. C (meningitis) does not explain the extreme CK elevation and myoglobinuria. D (delirium tremens) causes autonomic hyperactivity and agitation but not severe rigidity and massive rhabdomyolysis. E (immobility/agitation rhabdomyolysis) lacks an explanation for new fever and rigidity.\n\nMain medical accuracy issues: None significant; the associations and differentials are accurate. Minimal fix: explicitly state that an antipsychotic (e.g., haloperidol) was started for agitation to more transparently link the precipitant to NMS, though the item is already solvable.\n", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251225T200227925Z_deepseek-v3.2_seed134", "question_id": "20251225T200227925Z_deepseek-v3.2_seed134-004", "question": "A 67-year-old man presents with 6 months of progressive painless gross hematuria. Cystoscopy reveals a 3 cm papillary bladder tumor on the left lateral wall. Transurethral resection of bladder tumor (TURBT) pathology shows high-grade urothelial carcinoma invading into the muscularis propria (pT2). CT urogram shows no evidence of upper tract involvement or metastatic disease. He undergoes radical cystectomy with ileal conduit. Final pathology confirms pT2N0M0 disease. Three years later, surveillance CT shows a new 2.5 cm enhancing mass in the left renal pelvis, with no other metastases. What is the most appropriate next step in management?", "options": ["A. Percutaneous biopsy of the renal pelvis mass", "B. Systemic chemotherapy with gemcitabine and cisplatin", "C. Left nephroureterectomy with bladder cuff excision", "D. Radiation therapy to the renal pelvis mass", "E. Immunotherapy with pembrolizumab"], "answer": "C", "answer_index": 2, "explanation": "This represents a metachronous upper tract urothelial carcinoma (UTUC) after prior bladder cancer. The standard treatment for localized UTUC (especially in a solitary kidney or when contralateral kidney is normal) is radical nephroureterectomy with bladder cuff excision. Biopsy (A) is unnecessary as the imaging characteristics and history are highly suggestive of UTUC, and biopsy risks seeding. Systemic therapy (B or E) is reserved for metastatic or unresectable disease. Radiation (D) is not standard for UTUC. Given the prior cystectomy, the bladder cuff excision would involve removing the remnant ureteral stump.", "generator_model": "deepseek-v3.2", "seed": 134, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Urology", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: 67-year-old man with prior pT2N0M0 high‑grade urothelial carcinoma treated by radical cystectomy; three years later, a solitary 2.5‑cm enhancing mass in the left renal pelvis on CT, with no other metastases. This strongly indicates a localized metachronous upper tract urothelial carcinoma (UTUC) in a patient with an otherwise normal contralateral kidney (implied by lack of mention of renal dysfunction or solitary kidney).\\nChoice C (left nephroureterectomy with bladder cuff excision) is the standard treatment for localized high-risk UTUC in a surgically fit patient and matches guideline-based care. Biopsy (A) is not mandatory and risks tumor seeding; imaging plus history is usually sufficient. Systemic chemotherapy (B) or immunotherapy (E) are reserved for metastatic or unresectable disease or perioperative settings, not first-line definitive treatment for isolated localized UTUC. Radiation therapy (D) is non-standard as primary treatment in this setting.\\nMain logical issues: None; the case and options clearly support one best answer. Main medical accuracy issues: Minor—wording about solitary kidney could be clarified, but does not change the best choice.\\nMinimal fix: Explicitly state that renal function and contralateral kidney are normal to remove any residual ambiguity about nephron-sparing considerations.\",\"medical_accuracy_score\":\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: 67-year-old man with prior pT2N0M0 high‑grade urothelial carcinoma treated by radical cystectomy; three years later, a solitary 2.5‑cm enhancing mass in the left renal pelvis on CT, with no other metastases. This strongly indicates a localized metachronous upper tract urothelial carcinoma (UTUC) in a patient with an otherwise normal contralateral kidney (implied by lack of mention of renal dysfunction or solitary kidney).\nChoice C (left nephroureterectomy with bladder cuff excision) is the standard treatment for localized high-risk UTUC in a surgically fit patient and matches guideline-based care. Biopsy (A) is not mandatory and risks tumor seeding; imaging plus history is usually sufficient. Systemic chemotherapy (B) or immunotherapy (E) are reserved for metastatic or unresectable disease or perioperative settings, not first-line definitive treatment for isolated localized UTUC. Radiation therapy (D) is non-standard as primary treatment in this setting.\nMain logical issues: None; the case and options clearly support one best answer. Main medical accuracy issues: Minor—wording about solitary kidney could be clarified, but does not change the best choice.\nMinimal fix: Explicitly state that renal function and contralateral kidney are normal to remove any residual ambiguity about nephron-sparing considerations.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251225T200227925Z_deepseek-v3.2_seed134", "question_id": "20251225T200227925Z_deepseek-v3.2_seed134-005", "question": "A 24-year-old female is brought to the ED after being found unresponsive in her apartment. She has a known history of bipolar disorder. On arrival, she is comatose (GCS 3), afebrile, BP 85/40 mmHg, HR 45 bpm, SpO2 92% on room air. Pupils are 2 mm and sluggishly reactive. Bedside glucose is 110 mg/dL. ECG shows sinus bradycardia with a QRS duration of 140 ms and a terminal R wave in aVR. Arterial blood gas on room air shows pH 7.22, PaCO2 48 mmHg, PaO2 85 mmHg. What is the most appropriate immediate intervention?", "options": ["A. Administer 2 mg of intravenous naloxone", "B. Intubate for airway protection and initiate mechanical ventilation", "C. Administer 100 mEq of intravenous sodium bicarbonate", "D. Initiate transcutaneous pacing for symptomatic bradycardia", "E. Administer 100 mL of 20% intravenous lipid emulsion"], "answer": "C", "answer_index": 2, "explanation": "The ECG findings (wide QRS, terminal R in aVR) and clinical picture suggest a sodium channel blocker overdose (e.g., tricyclic antidepressant, which is common in bipolar disorder). Sodium bicarbonate is the first-line therapy to overcome sodium channel blockade, alkalinize the serum (increasing drug protein binding), and reduce cardiotoxicity. Bicarbonate corrects the acidosis, narrows the QRS, and improves blood pressure. Naloxone (A) is for opioids. Intubation (B) may be needed but does not treat the underlying cause. Pacing (D) is for refractory bradycardia but does not address the poisoning. Lipid emulsion (E) is for local anesthetic or other lipid-soluble drug overdoses, not typically first-line for TCAs.", "generator_model": "deepseek-v3.2", "seed": 134, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Emergency Medicine", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: Young woman with bipolar disorder (risk of TCA use in mood disorders), found comatose, hypotensive, bradycardic; ECG with markedly widened QRS (140 ms) and terminal R wave in aVR; metabolic acidosis on ABG (pH 7.22). This constellation is classic for sodium-channel–blocking cardiotoxic overdose such as tricyclic antidepressants. In that setting, hypertonic sodium bicarbonate is the established first-line immediate therapy to treat the cardiotoxicity by overcoming sodium channel blockade and alkalinizing serum.\\nOption C (IV sodium bicarbonate) directly addresses the life‑threatening toxidrome and matches current toxicology guidelines. Intubation (B) and mechanical ventilation are often required but are supportive; in exam logic, the more specific antidotal therapy is the “most appropriate immediate intervention” once the toxidrome is identified. Naloxone (A) is not indicated without clear opioid features (pinpoint pupils with hypoventilation and typical ECG). Pacing (D) does not treat the underlying poisoning and is not first line. Lipid emulsion (E) is reserved for refractory cases or specific local anesthetic toxicity.\\nMain medical issue: None significant; scenario and teaching point are accurate. Minimal fix: Clarify “most appropriate immediate pharmacologic intervention” to avoid debate with airway-first proponents.\\n\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: Young woman with bipolar disorder (risk of TCA use in mood disorders), found comatose, hypotensive, bradycardic; ECG with markedly widened QRS (140 ms) and terminal R wave in aVR; metabolic acidosis on ABG (pH 7.22). This constellation is classic for sodium-channel–blocking cardiotoxic overdose such as tricyclic antidepressants. In that setting, hypertonic sodium bicarbonate is the established first-line immediate therapy to treat the cardiotoxicity by overcoming sodium channel blockade and alkalinizing serum.\nOption C (IV sodium bicarbonate) directly addresses the life‑threatening toxidrome and matches current toxicology guidelines. Intubation (B) and mechanical ventilation are often required but are supportive; in exam logic, the more specific antidotal therapy is the “most appropriate immediate intervention” once the toxidrome is identified. Naloxone (A) is not indicated without clear opioid features (pinpoint pupils with hypoventilation and typical ECG). Pacing (D) does not treat the underlying poisoning and is not first line. Lipid emulsion (E) is reserved for refractory cases or specific local anesthetic toxicity.\nMain medical issue: None significant; scenario and teaching point are accurate. Minimal fix: Clarify “most appropriate immediate pharmacologic intervention” to avoid debate with airway-first proponents.\n", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251225T200227925Z_deepseek-v3.2_seed134", "question_id": "20251225T200227925Z_deepseek-v3.2_seed134-006", "question": "A 30-year-old woman with borderline personality disorder presents for outpatient follow-up. She reports chronic feelings of emptiness, intense fear of abandonment, and a pattern of unstable relationships. She has a history of recurrent self-cutting without suicidal intent. She asks about evidence-based psychotherapies specifically developed for her condition. Which of the following therapies has the strongest evidence base for reducing self-harm behaviors and hospitalizations in borderline personality disorder?", "options": ["A. Transference-Focused Psychotherapy (TFP)", "B. Mentalization-Based Treatment (MBT)", "C. Dialectical Behavior Therapy (DBT)", "D. Schema-Focused Therapy (SFT)", "E. Cognitive Behavioral Therapy (CBT) for personality disorders"], "answer": "C", "answer_index": 2, "explanation": "Dialectical Behavior Therapy (DBT) is the most extensively researched psychotherapy for borderline personality disorder and has the strongest evidence for reducing self-harm, suicide attempts, and hospitalizations. DBT was specifically developed for BPD and includes skills training in distress tolerance, emotion regulation, interpersonal effectiveness, and mindfulness. While MBT (B) and TFP (A) also have evidence, DBT has the most robust data for self-harm reduction. Schema therapy (D) and general CBT (E) have some evidence but are not as specifically targeted or as well-studied for self-harm outcomes in BPD as DBT.", "generator_model": "deepseek-v3.2", "seed": 134, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: 30-year-old woman with clear borderline personality disorder (chronic emptiness, intense fear of abandonment, unstable relationships, recurrent non-suicidal self-cutting) explicitly asks about “evidence-based psychotherapies specifically developed for her condition” and which has “the strongest evidence base for reducing self-harm behaviors and hospitalizations.” The intended construct is comparative evidence for BPD-specific therapies on self-harm/suicide/hospital use.\\nDBT was originally developed for chronically suicidal patients with BPD and has the largest and longest-standing RCT base showing reductions in self-harm, suicide attempts, and hospitalization days compared with treatment-as-usual and some active comparators. MBT and TFP have supportive data but a smaller and newer evidence base; CBT and schema therapy are less specifically tied to robust self-harm/hospitalization outcomes in BPD. Thus, DBT is the single best answer.\\nNo internal contradictions or underspecification are apparent; the question clearly asks for the “strongest evidence base,” not merely “effective therapy,” which discriminates among options.\\nMedical accuracy issues: None significant; statements about DBT’s evidence and targets (distress tolerance, emotion regulation, interpersonal effectiveness, mindfulness) are standard and current.\\nMinimal fix: Add “according to multiple randomized controlled trials and meta-analyses” to the stem or explanation to further clarify the evidence-based comparative framing.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: 30-year-old woman with clear borderline personality disorder (chronic emptiness, intense fear of abandonment, unstable relationships, recurrent non-suicidal self-cutting) explicitly asks about “evidence-based psychotherapies specifically developed for her condition” and which has “the strongest evidence base for reducing self-harm behaviors and hospitalizations.” The intended construct is comparative evidence for BPD-specific therapies on self-harm/suicide/hospital use.\nDBT was originally developed for chronically suicidal patients with BPD and has the largest and longest-standing RCT base showing reductions in self-harm, suicide attempts, and hospitalization days compared with treatment-as-usual and some active comparators. MBT and TFP have supportive data but a smaller and newer evidence base; CBT and schema therapy are less specifically tied to robust self-harm/hospitalization outcomes in BPD. Thus, DBT is the single best answer.\nNo internal contradictions or underspecification are apparent; the question clearly asks for the “strongest evidence base,” not merely “effective therapy,” which discriminates among options.\nMedical accuracy issues: None significant; statements about DBT’s evidence and targets (distress tolerance, emotion regulation, interpersonal effectiveness, mindfulness) are standard and current.\nMinimal fix: Add “according to multiple randomized controlled trials and meta-analyses” to the stem or explanation to further clarify the evidence-based comparative framing.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251225T200227925Z_deepseek-v3.2_seed134", "question_id": "20251225T200227925Z_deepseek-v3.2_seed134-007", "question": "A 19-year-old male with a history of autism spectrum disorder (level 1) is admitted to the inpatient psychiatry unit after he threatened his parents with a knife. He states that a 'voice from the computer' told him his parents were replaced by impostors. He has no prior psychiatric admissions. He is started on risperidone. Over the next 72 hours, he develops high fever (39.5°C), generalized muscle rigidity, labile blood pressure, and confusion. Creatine kinase is elevated at 5,000 U/L. Which of the following is the most appropriate next step in management?", "options": ["A. Switch risperidone to olanzapine and continue monitoring", "B. Administer intravenous dantrolene", "C. Administer intravenous bromocriptine", "D. Discontinue risperidone immediately and provide supportive care", "E. Add lithium carbonate to treat underlying mood disorder"], "answer": "D", "answer_index": 3, "explanation": "This is neuroleptic malignant syndrome (NMS), a life-threatening reaction to antipsychotics. The immediate and essential step is to discontinue the offending agent (risperidone). Supportive care (cooling, hydration, monitoring) is the cornerstone of management. While dantrolene (B) and bromocriptine (C) have been used as adjuncts in severe cases, they are not first-line and are reserved for refractory cases; their evidence is weak and they carry risks. Switching to another antipsychotic (A) or adding lithium (E) would be dangerous and could worsen NMS.", "generator_model": "deepseek-v3.2", "seed": 134, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: Recent initiation of risperidone; onset over 72 hours of high fever (39.5°C), generalized “lead-pipe” muscle rigidity, labile blood pressure, confusion, and markedly elevated CK (5,000 U/L). This classic tetrad strongly supports neuroleptic malignant syndrome (NMS). The key management principle is immediate discontinuation of the offending antipsychotic plus aggressive supportive care (IV fluids, cooling, monitoring for complications).\\nOption D explicitly states “Discontinue risperidone immediately and provide supportive care,” matching guideline-based first-line management. Options A and E are clearly unsafe; continuing or adding psychotropics during NMS is contraindicated. Options B (dantrolene) and C (bromocriptine) are potential *adjuncts* for moderate–severe or refractory NMS but are not preferred over, or done instead of, stopping the drug and supportive care; as written they omit the essential step of discontinuation and therefore are inferior as single best answers.\\nNo major medical inaccuracies are present; the explanation appropriately notes limited evidence for dantrolene/bromocriptine and prioritizes supportive care.\\nMinimal fix: Reword B and C to explicitly include discontinuation and supportive care (e.g., “After stopping risperidone and initiating supportive care, administer IV dantrolene”).\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: Recent initiation of risperidone; onset over 72 hours of high fever (39.5°C), generalized “lead-pipe” muscle rigidity, labile blood pressure, confusion, and markedly elevated CK (5,000 U/L). This classic tetrad strongly supports neuroleptic malignant syndrome (NMS). The key management principle is immediate discontinuation of the offending antipsychotic plus aggressive supportive care (IV fluids, cooling, monitoring for complications).\nOption D explicitly states “Discontinue risperidone immediately and provide supportive care,” matching guideline-based first-line management. Options A and E are clearly unsafe; continuing or adding psychotropics during NMS is contraindicated. Options B (dantrolene) and C (bromocriptine) are potential *adjuncts* for moderate–severe or refractory NMS but are not preferred over, or done instead of, stopping the drug and supportive care; as written they omit the essential step of discontinuation and therefore are inferior as single best answers.\nNo major medical inaccuracies are present; the explanation appropriately notes limited evidence for dantrolene/bromocriptine and prioritizes supportive care.\nMinimal fix: Reword B and C to explicitly include discontinuation and supportive care (e.g., “After stopping risperidone and initiating supportive care, administer IV dantrolene”).", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251225T200227925Z_deepseek-v3.2_seed134", "question_id": "20251225T200227925Z_deepseek-v3.2_seed134-008", "question": "A 72-year-old man with a history of benign prostatic hyperplasia presents with acute urinary retention. After placement of a Foley catheter, 1.2 L of clear urine is drained. Two days later, while the catheter is still in place, he becomes confused, tachycardic, and hypotensive. Serum sodium is 118 mEq/L (baseline 138 mEq/L 2 months ago). Urine sodium is 80 mEq/L, urine osmolality is 450 mOsm/kg, and serum osmolality is 255 mOsm/kg. What is the most likely cause of his hyponatremia?", "options": ["A. Syndrome of inappropriate antidiuretic hormone secretion (SIADH)", "B. Cerebral salt wasting syndrome", "C. Post-obstructive diuresis leading to volume depletion", "D. Psychogenic polydipsia", "E. Addison's disease"], "answer": "B", "answer_index": 1, "explanation": "This is cerebral salt wasting syndrome (CSWS), a rare cause of hyponatremia with natriuresis and volume depletion, often seen after neurosurgery or, as in this case, possibly after relief of urinary obstruction causing a transient cerebral event. The high urine sodium and volume depletion (hypotension, tachycardia) distinguish it from SIADH (A), which is euvolemic. Post-obstructive diuresis (C) can cause volume depletion but typically leads to loss of sodium and water, not isolated hyponatremia with high urine sodium. Psychogenic polydipsia (D) causes low serum and urine osmolality. Addison's (E) causes hyponatremia with hyperkalemia and low urine sodium.", "generator_model": "deepseek-v3.2", "seed": 134, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Urology", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: N\\nVerdict on keyed answer: No defensible answer (keyed answer also incorrect)\\nKey stem clues: Acute urinary retention relieved with Foley; 1.2 L initial drainage. Two days later: confusion, tachycardia, hypotension (suggesting volume depletion/shock). Labs: Na 118 mEq/L, serum Osm 255 (hypotonic hyponatremia), urine Na 80 mEq/L, urine Osm 450 (inappropriately concentrated, high urine Na).\\nMain logical/medical issues: Cerebral salt wasting is classically associated with intracranial pathology (SAH, neurosurgery, CNS infection/trauma); the stem provides no CNS event and invents an unsupported “transient cerebral event” after bladder decompression, which is not accepted teaching. Post‑obstructive diuresis is a known consequence of relief of urinary retention and typically presents with polyuria, natriuresis, and volume depletion; hyponatremia can occur from renal salt loss with hypotonic fluid intake—this mechanism best fits the clinical context, but the item’s explanation incorrectly dismisses it. Several options are poorly specified, and none perfectly match the combination of lab and volume status without additional assumptions.\\nMinimal fix: Explicitly describe large ongoing post‑obstructive urine output with natriuresis and clarify in the explanation that this post‑obstructive diuresis is causing hypovolemic hyponatremia; change the key to C and remove the speculative cerebral salt wasting link.\\n\",\"medical_accuracy_score\":\"2\",\"logical_validity\":false,\"logical_false_reason\":\"N\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: N\nVerdict on keyed answer: No defensible answer (keyed answer also incorrect)\nKey stem clues: Acute urinary retention relieved with Foley; 1.2 L initial drainage. Two days later: confusion, tachycardia, hypotension (suggesting volume depletion/shock). Labs: Na 118 mEq/L, serum Osm 255 (hypotonic hyponatremia), urine Na 80 mEq/L, urine Osm 450 (inappropriately concentrated, high urine Na).\nMain logical/medical issues: Cerebral salt wasting is classically associated with intracranial pathology (SAH, neurosurgery, CNS infection/trauma); the stem provides no CNS event and invents an unsupported “transient cerebral event” after bladder decompression, which is not accepted teaching. Post‑obstructive diuresis is a known consequence of relief of urinary retention and typically presents with polyuria, natriuresis, and volume depletion; hyponatremia can occur from renal salt loss with hypotonic fluid intake—this mechanism best fits the clinical context, but the item’s explanation incorrectly dismisses it. Several options are poorly specified, and none perfectly match the combination of lab and volume status without additional assumptions.\nMinimal fix: Explicitly describe large ongoing post‑obstructive urine output with natriuresis and clarify in the explanation that this post‑obstructive diuresis is causing hypovolemic hyponatremia; change the key to C and remove the speculative cerebral salt wasting link.\n", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "N", "verdict": "FAIL", "fail_reason": "N"}, "judge_verdict": "FAIL", "judge_fail_reason": "N", "judge_medical_accuracy_score": 2}]